Rejuve Therapeutics Inc

Osiris Therapeutics is a company founded to commercialize stem cell products from adult bone marrow. These stem cells have demonstrated the ability to repair different types of tissues. Osiris Therapeutics is commercializing products from a readily available and noncontroversial source, which is adult bone marrow. These stem cells have demonstrated the ability to repair different types of tissue and offer a real opportunity to develop revolutionary new treatments for certain disease processes, which includes autoimmune disorders, heart attacks and arthritis. Osiris Therapeutics is located in Baltimore.

ReveraGen Biopharma, located in Rockville, MD, is a pioneering company in the field of drug development, particularly known for its innovative approach to steroid chemistry and clinical trial design. The company is recognized for its successful venture philanthropy model, which aims to benefit non-profit organizations through advancements in therapeutic solutions. The company's groundbreaking therapy, vamorolone, has recently become the first treatment for Duchenne muscular dystrophy (DMD) to receive approvals from both the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). This dual approval marks a significant milestone in the treatment landscape for DMD, showcasing ReveraGen's commitment to addressing rare muscular disorders and improving patient outcomes. Generated from the website

IDT Biologika Corporation, founded in 1921, is a leading global contract development and manufacturing organization (CDMO) specializing in the end-to-end development and manufacturing of viral vaccines, gene immune therapeutics, and sterile injectables. With over 600 employees and substantial investments exceeding 600 million euros, the company leverages over a century of expertise to support pharmaceutical and biotech companies in delivering life-saving treatments worldwide. Headquartered in Rockville, MD, IDT Biologika operates state-of-the-art BSL-2 facilities and offers a full spectrum of services, including process development, viral vector production, and analytical development. Recognized for its commitment to quality and compliance, the company has established itself as a trusted partner for over 200 clinical and commercial projects, continually innovating to meet growing global demands. Generated from the website